Bevacizumab vs Lisinopril

## Bevacizumab vs Lisinopril: Overview

This comparison examines the pharmacological differences between **Bevacizumab** and **Lisinopril**.

## Mechanism of Action

**Lisinopril**: ACE inhibitor preventing conversion of angiotensin I to angiotensin II.

## Pharmacokinetics

**Half-life**: Bevacizumab — N/A; Lisinopril — 12 hours.

## Chemical Properties

**Molecular Formula**: Bevacizumab — N/A; Lisinopril — C21H31N3O5.

**Molecular Weight**: Bevacizumab — N/A; Lisinopril — 405.4900 g/mol.

**Type**: Bevacizumab — Antibody; Lisinopril — Small molecule.